BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15491558)

  • 1. Medical treatment of missed abortion using misoprostol.
    Ngoc NT; Blum J; Westheimer E; Quan TT; Winikoff B
    Int J Gynaecol Obstet; 2004 Nov; 87(2):138-42. PubMed ID: 15491558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual vs vaginal misoprostol for completion of first trimester missed abortion: a randomised controlled trial.
    Abdelshafy A; Awwad H; Abo-Gamra A; Alanwar A; Elkotb AM; Shahin M; Abd El-Razek M; Abbas AM
    Eur J Contracept Reprod Health Care; 2019 Apr; 24(2):134-139. PubMed ID: 30747547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravaginal misoprostol 600 microg and 800 microg for the treatment of early pregnancy failure.
    Kovavisarach E; Jamnansiri C
    Int J Gynaecol Obstet; 2005 Sep; 90(3):208-12. PubMed ID: 15967450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose misoprostol used in outpatient management of first trimester spontaneous abortion.
    Sifakis S; Angelakis E; Vardaki E; Fragouli Y; Koumantakis E
    Arch Gynecol Obstet; 2005 Sep; 272(3):183-6. PubMed ID: 15909189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
    Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
    Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
    Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol to treat missed abortion in the first trimester.
    Gemzell-Danielsson K; Ho PC; Gómez Ponce de León R; Weeks A; Winikoff B
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S182-5. PubMed ID: 17961567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual misoprostol in management of missed abortion in India.
    Sharma D; Singhal SR; Rani XX
    Trop Doct; 2007 Jan; 37(1):39-40. PubMed ID: 17326888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined administration of misoprostol in the first and second trimester missed abortion cases.
    Kutlu T; Tuğrul S; Aran T; Uslu H; Eren S; Oral O
    Clin Exp Obstet Gynecol; 2006; 33(4):226-8. PubMed ID: 17211971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal misoprostol in the management of first-trimester missed abortions.
    Ayres-de-Campos D; Teixeira-da-Silva J; Campos I; Patrício B
    Int J Gynaecol Obstet; 2000 Oct; 71(1):53-7. PubMed ID: 11044543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with misoprostol in the management of missed abortion in the second trimester.
    Menakaya U; Otoide V; Omo Aghoja L; Odunsi K; Okonofua F
    J Obstet Gynaecol; 2005 Aug; 25(6):583-5. PubMed ID: 16234145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of misoprostol with and without letrozole on the induction of abortion for women with first-trimester missed abortion.
    Allameh Z; Goharian M; Eslamian M
    Int J Gynaecol Obstet; 2020 Nov; 151(2):214-218. PubMed ID: 32700359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual versus vaginal misoprostol in the management of missed miscarriage.
    Shah N; Azam SI; Khan NH
    J Pak Med Assoc; 2010 Feb; 60(2):113-6. PubMed ID: 20209697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.